Avastin versus Lucentis Comparative Studies Proliferate – France Joins the Fray
September 24, 2009
As I have just reported on my online Journal, there are now at least six countries studying whether Avastin is a suitable, lower-cost replacement for Lucentis in treating wet age-related macular degeneration. Studies are underway in the U.S., UK, Austria, Germany, Spain, and now in France.
For the latest about the French study, please see my Avastin/Lucentis Update 25.
I expect that, although the CATT Study one-year results probably will not be released until next Spring, some initial thoughts might be heard at the upcoming AAO Meeting in San Francisco. If so, I hope to report on those thoughts in this space following the meeting.
Source: APM Health Europe
Jump down to form below to submit your own comments